Article citationsMore>>
P. Schoffski, R. Elisei, S. Muller, M. S. Brose, M. H. Shah, L. F. Licitra, B. Jarzab, V. Medvedev, M. Kreissl, B. Niederle, E. E. W. Cohen, L. J. Wirth, H. Y. Ali, C. Hessel, Y. Yaron, D. W. Ball, B. Nelkin, S. I. Sherman and M. Schlumberger, “An International, Double-Blind, Randomized, Placebo-Controlled Phase III Trial (EXAM) of Cabozantinib (XL184) in Medullary Thyroid Carcinoma (MTC) Patients (pts) with Documented RECIST Progression at Baseline.,” Journal of Clinical Oncology, Vol. 30, 2012, Abstract No. 5508.
has been cited by the following article:
Related Articles:
-
Anestakis Doxakis, Argyraki Maria, Petanidis Savvas, Iakovidou-Kritsi Zafiroula
-
Andrew Beckwith
-
Arezoo Omati, Kambiz Davari, Borhan Shokrolahi
-
Tatsuya Izumi, Kazuo Yamamoto, Naoko Suzuki, Shin-ichiro Yamashita, Shin-ichiro Iio, Hayata Noguchi, Toshihiro Kakinuma, Asami Baba, Shogo Takeda, Wakana Yamada, Hiroshi Shimoda
-
Casimir Komenan